ArticleThe oncologist2023

Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment.

Chenchen Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.